000			02092 a2200577 4500
005			20250516121625.0
264		0	_c20131126
008			201311s 0 0 eng d
022			_a1468-2060
024	7		_a10.1136/annrheumdis-2012-202229 _2doi
040			_aNLM _beng _cNLM
100	1		_aKristensen, Lars Erik
245	0	0	_aLong-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cOct 2013
300			_a1675-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdalimumab
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aArthritis, Psoriatic _xdrug therapy
650	0	4	_aCohort Studies
650	0	4	_aDisability Evaluation
650	0	4	_aEtanercept
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xtherapeutic use
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPain Measurement _xmethods
650	0	4	_aPensions _xstatistics & numerical data
650	0	4	_aReceptors, Tumor Necrosis Factor _xtherapeutic use
650	0	4	_aSeverity of Illness Index
650	0	4	_aSex Factors
650	0	4	_aSick Leave _xstatistics & numerical data
650	0	4	_aSweden _xepidemiology
650	0	4	_aTreatment Failure
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aYoung Adult
700	1		_aEnglund, Martin
700	1		_aNeovius, Martin
700	1		_aAskling, Johan
700	1		_aJacobsson, Lennart T H
700	1		_aPetersson, Ingemar F
773	0		_tAnnals of the rheumatic diseases _gvol. 72 _gno. 10 _gp. 1675-9
856	4	0	_uhttps://doi.org/10.1136/annrheumdis-2012-202229 _zAvailable from publisher's website
999			_c22260545 _d22260545